Assessment of a community pharmacy-based program for patients with asthma

Pharmacotherapy. 2001 Oct;21(10):1196-203. doi: 10.1592/phco.21.15.1196.33894.


Study objective: To implement and assess a community-based pharmaceutical care program for patients with asthma.

Design: Prospective, randomized, controlled trial.

Setting: Community pharmacies (11 control, 11 intervention) in Malta.

Patients: Community-dwelling patients with asthma.

Interventions: A comprehensive asthma education and monitoring program was implemented. Intervention patients received verbal counseling, an educational video, an information leaflet, and subsequent monitoring with reinforcement; control patients received routine dispensing services.

Measurements and main results: Parameters assessed at baseline and at 4, 8, and 12 months were health-related quality of life, peak expiratory flow (PEF), inhaler technique, compliance with therapy, hospitalization rates, days lost from work, asthma symptoms, and patient satisfaction. Health-related quality of life of the intervention patients improved at 12 months (p=0.044). In the same time period, PEF significantly decreased in control patients compared with intervention patients (p=0.009) whereas inhaler technique improved in the intervention group (p=0.021). There were significantly fewer self-reported hospitalizations in intervention patients.

Conclusions: A community-based pharmaceutical care program was appreciated by the participants and had a positive impact on the vitality of patients with asthma, inhaler technique, and PEE.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Asthmatic Agents / administration & dosage
  • Anti-Asthmatic Agents / therapeutic use*
  • Asthma / drug therapy*
  • Asthma / psychology
  • Community Pharmacy Services*
  • Drug Monitoring
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Nebulizers and Vaporizers
  • Patient Education as Topic / methods*
  • Pharmacists
  • Prospective Studies
  • Quality of Life
  • Treatment Outcome


  • Anti-Asthmatic Agents